Javascript must be enabled to continue!
Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt‐Jakob disease
View through CrossRef
BACKGROUND: Concern over the theoretical possibility of disease transmission via blood from donors who develop Creutzfeldt‐Jakob disease has led to proposals to exclude older individuals from donating plasma for further manufacture into pooled plasma donations. The impact of extending this age‐deferral policy to blood donors was examined with respect to the risk for known transmissible viruses. STUDY DESIGN AND METHODS: Demographic characteristics and confirmed prevalence rates (/10(5) first‐time donations) and incidence rates (/10(5) person‐years for repeat donors) for viral markers were compared for donors < 50 years old (n = 1,259,805 [85%]) and > or = 50 years old (n = 219,856 [15%]) and for donors < 60 years old (n = 1,409,176 [95%]) and > or = 60 years old (n = 70,485 [5%]). Incidence rates were combined with infectious window‐period estimates for each virus, to calculate the risk of virus transmission per 10(6) donations. RESULTS: Unadjusted prevalence rates were significantly greater for younger than for older donor groups for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) (p < or = 0.05). Incidence rates (and transmission risk estimates) for HBsAg were significantly higher in the < 50 donor group than in the > or = 50 group (p < or = 0.05), and those for HIV, human T‐lymphotropic virus, and HCV were not significantly higher (p > 0.05). Blanket removal of donors over the age of 50 would potentially lead to the following significant increases in the risk of infected units: HIV, 12 percent; HCV, 21 percent; and hepatitis B virus (HBsAg), 22 percent. CONCLUSION: Removal of donors over the age of 60 would not significantly affect the risk of infected units. Deferral of donors > or = 50 years of age from whole‐blood donations for unfounded concerns about Creutzfeldt‐Jakob disease could have adverse effects on both blood availability and safety.
Title: Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt‐Jakob disease
Description:
BACKGROUND: Concern over the theoretical possibility of disease transmission via blood from donors who develop Creutzfeldt‐Jakob disease has led to proposals to exclude older individuals from donating plasma for further manufacture into pooled plasma donations.
The impact of extending this age‐deferral policy to blood donors was examined with respect to the risk for known transmissible viruses.
STUDY DESIGN AND METHODS: Demographic characteristics and confirmed prevalence rates (/10(5) first‐time donations) and incidence rates (/10(5) person‐years for repeat donors) for viral markers were compared for donors < 50 years old (n = 1,259,805 [85%]) and > or = 50 years old (n = 219,856 [15%]) and for donors < 60 years old (n = 1,409,176 [95%]) and > or = 60 years old (n = 70,485 [5%]).
Incidence rates were combined with infectious window‐period estimates for each virus, to calculate the risk of virus transmission per 10(6) donations.
RESULTS: Unadjusted prevalence rates were significantly greater for younger than for older donor groups for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) (p < or = 0.
05).
Incidence rates (and transmission risk estimates) for HBsAg were significantly higher in the < 50 donor group than in the > or = 50 group (p < or = 0.
05), and those for HIV, human T‐lymphotropic virus, and HCV were not significantly higher (p > 0.
05).
Blanket removal of donors over the age of 50 would potentially lead to the following significant increases in the risk of infected units: HIV, 12 percent; HCV, 21 percent; and hepatitis B virus (HBsAg), 22 percent.
CONCLUSION: Removal of donors over the age of 60 would not significantly affect the risk of infected units.
Deferral of donors > or = 50 years of age from whole‐blood donations for unfounded concerns about Creutzfeldt‐Jakob disease could have adverse effects on both blood availability and safety.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Infections of Hepatitis B and C and Malaria Plasmodium Falciparum among Blood Donors in Ife East Local Government Area, Ile Ife, Osun State, Nigeria
Endemic regions for malaria are endemic for other infectious diseases that might affect the malaria infection. Infection with
hepatitis B virus (HBV) and hepatitis C virus (HCV) ar...
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Follow-up of 12,559 Unrelated Donors of Peripheral Blood Stem Cells or Bone Marrow
Abstract
Abstract 365
Donor follow-up is indicated to detect potential long-term risks for allogeneic stem cell donors. We sent a follow-up questionna...
Dysmyelopoiesis In Healthy Bone Marrow Donors
Dysmyelopoiesis In Healthy Bone Marrow Donors
Abstract
Abstract 4006
Background:
According to WHO, the recommended requisite percentage of cells manifesting dy...
Human immunodeficiency virus test‐seeking motivation in blood donors, São Paulo, Brazil
Human immunodeficiency virus test‐seeking motivation in blood donors, São Paulo, Brazil
Background and Objective Previous studies have shown that volunteer, community‐recruited donors have a higher prevalence of human immunodeficiency virus (HIV) infection in São Pau...
Sporadic Creutzfeldt–Jakob Disease
Sporadic Creutzfeldt–Jakob Disease
Abstract
Sporadic Creutzfeldt–Jakob disease is a rare and fatal human prion disease characterized by a rapidly progressive dementia, myoclonus, cerebellar, pyrami...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...

